Immune checkpoints represent a promising breakthrough in targeted therapy and prognosis of myelodysplastic syndrome

Myelodysplastic syndrome (MDS) is a hematological malignancy of undetermined etiology, possibly linked to chromosomal structural alterations, genetic mutations, presentation and carcinogenicity of variant antigens on cell surface, and the generation of pro-inflammatory microenvironment in the bone m...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Xinyu, Yu, Shunjie, Ren, Xiaotong, Li, Lijuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558320/
https://www.ncbi.nlm.nih.gov/pubmed/37810157
http://dx.doi.org/10.1016/j.heliyon.2023.e19222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558320/
https://www.ncbi.nlm.nih.gov/pubmed/37810157
http://dx.doi.org/10.1016/j.heliyon.2023.e19222

Ejemplares similares